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N octuria is defined by the International Continence Society (ICS) as 'the complaint that the individual has to wake at night one or more times to void […] each void is preceded and followed by sleep, ' 1,2 and has a significant effect on quality of life. [3] [4] [5] [6] Many GPs believe that they rarely see this condition in their practice. There are many published guidelines on nocturia; however, most are of little practical relevance to GPs. Table 1 outlines a checklist to help assess presenting symptoms and their potential causes. Box 1 provides examples of typical Patient on medication that may precipitate nocturia, such as calcium channel blockers, thiazides or GABA-ergic agents
Trial stopping the medication to see if it is causing or exacerbating the condition, if appropriate Move diuretic doses to the mid-afternoon
Patient presenting with tiredness or a history of loud snoring or breathing which repeatedly stops and starts during sleep (to be corroborated by partner) 7 
Consider sleep apnoea Ask the partner (if possible) Use the STOP-BANG questionnaire to assess for sleep apnoea If STOP-BANG is positive, Epworth Sleepiness Scale questionnaire can be used to refine the diagnosis
Obese/overweight patients Consider metabolic syndrome or prediabetes
History of enuresis May be associated with chronic retention of urine -arrange bladder/renal ultrasound
Other medical conditions: -Heart disease -Asthma -Benign prostatic hyperplasia -Uterine prolapse -Hypertension -Irritable bowel syndrome -Prostatitis -Hysterectomy -Arthritis -Recurrent urinary tract infection -Prostate cancer -Anxiety and depression Comorbidities that may be contributing to nocturia questions GPs can ask to help identify the cause of a patient's urinary symptoms. In order to be diagnosed with nocturia, the following conditions should be met:
• Two voids per night, leading to poor sleep quality (less than four hours sleep per night) • Waking up to void the bladder.
INVESTIGATIONS IN PRIMARY CARE
Core and optional investigations are outlined in Box 2. The frequencyvolume chart (FVC) is a key diagnostic and monitoring tool for identifying and managing nocturia. It monitors the amount and type of fluid taken in. FVCs document the time of each void, voided volume per micturition, the time of going to bed with the intention of sleeping, and the time of waking up for each additional void, as well as the time for waking up with the intention of starting the day.
Nocturnal urine volume describes the amount of urine excreted during the night time, including the volume of the first morning void after waking because this urine has been produced during the night time. FVC also records time to bed and time to first void, providing an indication of the quality of sleep.
Patients are advised to use the FVC at a time convenient for them, eg over a weekend. It is important to emphasise the importance of this tool to the patients for both assessing and monitoring their condition. Box 3 provides an interpretation of an FVC. Box 4 provides a summary of storage and voiding symptoms.
Box 1. Assessment questions PROACTIVELY ASK THE PATIENT ABOUT NOCTURIA SYMPTOMS IF:
• The patient presents with concerns about prostate cancer/ wants a PSA
• The patient is concerned about being consistently tired
• The patient has had night-time falls (especially the elderly)
• The patient presents with or has a history of heart failure
• A female patient is menopausal TYPICAL QUESTIONS:
• How many times do you get up at night, and what is the reason for each awakening?
• How much and what do you drink before bedtime?
• Is it a full bladder that wakes you, or do you wake up and then decide to go to the toilet?
• What is your usual wake-up time in the morning?
• Do you feel that your quality of sleep has been affected, ie are you getting at least four hours of uninterrupted sleep?
• 
Pharmacological approaches
Treatment with pharmacological medicine depends on the underlying cause of nocturia. Pharmacological agents include diuretics, antidiuretic agents (desmopressin), antimuscarinic agents, and alpha-adrenergic blockers.
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Alpha blockers
• NICE guidance recommends adding antimuscarinics with alpha-adrenergic blockers for men who still have storage symptoms after treatment with an alpha blocker alone. 
Antimuscarinics
• Antimuscarinics are given for the management of symptoms of overactive bladder (OAB). 9 The number of nocturnal voids has been shown to decrease to a greater extent with combination treatment of an antimuscarinic agent and mirabegron (a β 3 -adrenoceptor agonist) versus alpha-adrenergic blocker/antimuscarinic monotherapy, while overall tolerability remains similar.
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Diuretic agents
• Diuretics are considered when there are more voids at night versus daytime. 12 • Monitor treatment response to prevent adverse events, electrolyte imbalances and decline in renal function. 13 
Antidiuretic agents
• Desmopressin can be used for patients with nocturia due to nocturnal polyuria. [14] [15] [16] [17] Surgical options 9, 10 • Bladder outlet obstruction-reducing procedures may improve nocturia in some patients with voiding lower urinary tract symptoms (LUTS) and bladder outlet obstruction who fail medical therapy and who are good surgical candidates.
• Surgery for the relief of bladder outlet obstruction is not indicated for the management of patients whose primary complaint is nocturia.
Expected outcomes of management
• Expected outcomes should include: Elimination or decrease in episodes of nocturia to ≥1 episode per night • Improved quality of sleep -at least four hours of sleep per night CONCLUSIONS Nocturia is a multifactorial disorder related to other comorbidities and not necessarily related to the bladder or prostate. Nocturia leads to impaired quality of life, and its management should be based on a holistic approach that targets the underlying causes.
The FVC is an essential evaluation tool that can facilitate accurate identification of the potential causes of nocturia in an individual patient. Behavioural treatments and lifestyle interventions should be tried. If these fail, pharmacological agents can be used.
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Presentation
A 52-year-old female presented with two years worsening urinary symptoms, daytime frequency and urgency, occasional urgency incontinence, and two to three episodes of nocturia per night. She wakes with urgent desire to void at times. There are no UTIs, and no haematuria. She is perimenopausal, and reported drinking four to five mugs of tea per day, plus one coffee.
Medical History
Otherwise fit and well -no significant past medical history
Physical Examination • Abdominal examination normal • Vaginal examination -mild to moderate atrophic changes • Urinalysis normal
Diagnosis
Overactive bladder
Management
• Advised on fluid management -minimise caffeine intake, aim for 1.5-2L 24 hour total intake, minimise fluid intake in the four hours before bed • Topical vaginal oestrogen twice weekly • Verbal and written information regarding simple bladder training measures
Follow-up
• Reviewed at six weeks -some improvement but bothersome symptoms remain • Trial of an anti-muscarinic recommended -aim to try discontinuing this after other measures have had a chance to work
Case study -overactive bladder Presentation
A 62-year-old man presented with increasing LUTS that were beginning to cause bother. He reported hesitancy, moderate stream, frequency (especially after drinking coffee), nocturia four times per night, plus a sensation of incomplete emptying on occasion. Symptoms also include a tendency for a little urge incontinence if emptying is delayed, encouraging the patient to pass urine frequently during the day. Loss of sleep is causing the most bother. IPSS score 26, QOL 4. 
Medical History
Presentation
A 62-year-old male presented with two to three years increasing daytime urinary frequency, up to eight times a day, and nocturia two to three times a night. He also reported post-micturition dribbling and poor urinary stream in terms of flow rate and spray. It was the mess caused by the latter symptoms which prompted his wife to push him to see his GP. There was no history of visible haematuria, dysuria or urge incontinence. 
Medical History
Diagnosis
A presumptive diagnosis of BPH was made pending further investigations
Management
• Lifestyle advice given, as much to help his diabetes and BP as anything else • Urine dipstick test normal
• Blood was sent for renal function (normal) and, after appropriate counselling, PSA (3.8)
• Asked to fill in a three-day frequency volume chart, which showed a reasonable fluid intake and confirmed stated small volume frequency and nocturia • Tamsulosin MR 400mcg daily • Improvement in symptoms reported after one week, with a reduction in frequency to five times a day and a reduction in nocturia to one to two times a night, which the patient found acceptable.
Follow-up
Symptoms remained stable for approximately two years. The patient then returned to see his GP with a recurrence of the same initial symptoms, possibly worse. Examination revealed further enlargement of his prostate (40g+) which remained smooth. His PSA had risen to 4.7.
The patient was referred for an ultrasound scan, which showed normal kidneys and ureters, but a trabeculated bladder wall and an enlarged prostate of 50g. He voided 257ml of urine, leaving a residual volume of 122ml.
He was commenced on finasteride 5mg, in addition to his tamsulosin, with a warning that it may have an adverse effect on sexual activity.
After two to three months, the patient noticed an improvement in his LUTS, which has been sustained to date. His PSA had fallen to 3.1 after six months on finasteride and continues to fluctuate between 3 and 4. His current LUTS are acceptable. He is aware that the next step may involve surgery or laser treatment.
Case study -benign prostatic hyperplasia (BPH; enlarged prostate) Presentation
A 52-year-old woman presented with frequency and urgency of urine during the day and nocturia four to five times a night. She reported having had symptoms for two years, but they had worsened in the last year. She also suffers flushing and thinks this may wake her at night; she tends to void as she is awake. She works as a secretary and feels so tired that she is just not coping; she is worried that she is not doing her job properly. She reported that she keeps forgetting things, but is not sure whether this is because she is tired or menopausal. Her libido is low, but again she thinks this is because she is tired. She also has vaginal dryness but uses lubricant, which helps. 
Medical history
Diagnosis
Menopausal overactive bladder
Management
The patient was asked about the most bothersome symptom and whether she had thought about trying anything. She had tried phyto-oestrogen tablets OTC for six months, but these had not helped.
HRT and risks versus benefits were discussed. The patient was worried about reports in the media and about heart attacks. It was explained that the reports were based on older studies with combined HRT, that she could have oestrogen only (as she had no uterus), and that there was only a slightly increased risk of breast cancer. Topical versus oral versus patch HRT was discussed. The patient had no family history of breast cancer or DVT.
Frequency-volume chart (FVC): the patient has a sensible fluid intake, but drinks six cups of coffee and two cups of tea per day -frequency and urgency are worse in the day. Cutting down caffeine intake was discussed. The patient is happy to do this and will consider fruit tea, de-caffeinated tea /coffee, or water.
Nocturia: 150-200mls, and the patient feels that it is hot flushes waking her up rather than bladder symptoms. She reported having to throw the bed covers off due to feeling hot, but then feeling cold and needing to void. She also has a drink as she is thirsty.
The patient would like to try oral HRT, as she thinks that if she can control the flushes, she may not wake up so much, and she needs a better night's sleep. She is not keen on trying patches as she has an allergy to plaster; also, she has been told by friends that the patches fall off when they get hot.
Low-dose oestrogen 1mg prescribed. The patient will adjust fluid intake as discussed.
Follow-up
Repeat FVC at four to six weeks. Adjusting fluid intake has helped with daytime symptoms (if urgency had persisted, an anticholinergic could have been considered, but it is not necessary in this case).
The patient understands that it is still early days with regard to the HRT, but thinks that her flushes are already less, and she is now only getting up twice during the night. HRT will be reviewed at three months, at which point it can either increase or stay the same.
Presentation
A 71-year-old businessman presented reporting that he was finding it difficult to sleep at night. On further questioning, he reported waking three to four times at night with the need to pass urine. He passes 'good' volumes and has a good flow with no other voiding symptoms. He occasionally has some urgency, but no episodes of urge incontinence. He is a smoker and drinks four cups of coffee day. 
Medical History
